MIT engineers report a new approach to identifying protein structures key to Alzheimer’s disease, an important step toward the development of new drugs that could prevent such structures from forming. «more»

Related Links:

MIT zeroes in on Alzheimer’s structures: Work could lead to new drugs for the common disease

Professor Collin M. Stultz

RLE Computational Biophysics Group